AZN ALXN1210-TMA-313 Phase 3 clinical trial did not meet the primary endpoint.
AZN ALXN1210-TMA-313 Phase 3 clinical trial did not meet the primary endpoint.
AZN ALXN1210-TMA-313 Phase 3 clinical trial did not meet the primary endpoint.
AZN ALXN1210-TMA-313 Phase 3 clinical trial did not meet the primary endpoint.
AZN ALXN1210-TMA-313 Phase 3 clinical trial did not meet the primary endpoint.